摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (E)-6-methyl-9-phenylnon-4-enoate | 146558-16-9

中文名称
——
中文别名
——
英文名称
methyl (E)-6-methyl-9-phenylnon-4-enoate
英文别名
——
methyl (E)-6-methyl-9-phenylnon-4-enoate化学式
CAS
146558-16-9
化学式
C17H24O2
mdl
——
分子量
260.376
InChiKey
MUCQLBPOCARGBY-RMKNXTFCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    359.3±31.0 °C(Predicted)
  • 密度:
    0.970±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    19
  • 可旋转键数:
    9
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] COMPOSITIONS<br/>[FR] COMPOSITIONS
    申请人:SAN RAFFAELE CENTRO FOND
    公开号:WO2011077245A2
    公开(公告)日:2011-06-30
    The invention relates to the discovery that human and murine tumors release LXR ligands (oxysterols) that inhibit CCR7 expression on maturing DC and, therefore, their migration to lymphoid organs. By inhibiting oxysterol synthesis (by Zaragozic Acid, ZA) or by inactivating oxysterols (gene therapy with sulfotransferase SULT2B1 b enzyme) long lasting antigen specific anti-tumor immune response mediated by DC is increased. Surprisingly, we also show that drugs interfering with sterol metabolism (i.e. ZA) in combination with a mAb depleting T regulatory cells potentiate the antitumor effect of the single treatments. This synergic effect is unexpected, providing a new effective combination therapy for the treatment of cancer. The invention also relates to the novel use of LXR ligand inactivators, or of LXR inhibitors/antagonists, for the treatment of cancer. These strategies can also be used in combination with a chemotherapy approach for the treatment of cancer patients.
  • The isolation and structure elucidation of zaragozic acid C, a novel potent squalene synthase inhibitor.
    作者:Claude Dufresne、Kenneth E. Wilson、Deborah Zink、Jack Smith、James D. Bergstrom、Marc Kurtz、Deborah Rew、Mary Nallin、Rosalind Jenkins、Ken Bartizal、Charlotte Trainor、Gerald Bills、Maria Meinz、Leeyuan Huang、Janet Onishi、James Milligan、Marina Mojena、Fernando Pelaez
    DOI:10.1016/s0040-4020(01)88327-7
    日期:1992.11
    The novel zaragozic acid C (1) has been isolated as a potent inhibitor of squalene synthase. It was found to be a competitive inhibitor of rat liver squalene synthase with an apparent Ki of 45 ± 15 pM, and a broad spectrum antifungal agent against both yeast and filamentous fungi.
    新型zaragozic酸C(1)已被分离为鲨烯合酶的有效抑制剂。已发现它是大鼠肝角鲨烯合酶的竞争性抑制剂,表观K i为45±15 pM,并且是针对酵母和丝状真菌的广谱抗真菌剂。
查看更多